PMID- 26121457 OWN - NLM STAT- MEDLINE DCOM- 20160815 LR - 20210204 IS - 1530-891X (Print) IS - 1530-891X (Linking) VI - 21 IP - 9 DP - 2015 Sep TI - HLA DQ2 HAPLOTYPE, EARLY ONSET OF GRAVES DISEASE, AND POSITIVE FAMILY HISTORY OF AUTOIMMUNE DISORDERS ARE RISK FACTORS FOR DEVELOPING CELIAC DISEASE IN PATIENTS WITH GRAVES DISEASE. PG - 993-1000 LID - 10.4158/EP15700.OR [doi] AB - OBJECTIVE: The diagnosis of celiac disease (CD) in patients with different autoimmune diseases including Graves disease (GD) remains a challenge. The aims of our study were to: (1) assess the prevalence of CD in Polish patients with GD and (2) evaluate the prevalence of CD in the subgroups of patients with GD divided on the basis of clinical and human leukocyte antigen (HLA) typing criteria. METHODS: The prospective study was conducted at an academic referral center. The study groups consisted of consecutive, euthyroid patients with GD (n = 232) and healthy volunteers without autoimmune thyroid diseases (n = 122). The diagnosis of CD was based on elevated immunoglobulin A autoantibodies to the enzyme tissue transglutaminase (IgA-TTG) and small intestine biopsy findings. RESULTS: CD was diagnosed in 8 patients with GD (3.4%) and 1 healthy volunteer (0.8%). The development of CD in patients with GD was strongly associated with HLA-DQ2 haplotype (as predicted from linkage disequilibria, 14.6% vs. 1.5%, P = .009; odds ratio [OR] = 11.3; 95% confidence interval [CI] 1.3-252.7): 6 patients with CD carried HLA-DRB1(*)03, 1 carried an HLA-DRB1(*)04 allele, and 1 had an HLA-DRB1(*)07/(*)11 genotype. Multivariate analysis showed independent associations between CD and early GD onset (P = .014, OR = 9.6), autoimmunity in family (P = .029, OR = 6.3) and gastroenterologic symptoms (P = .031, OR = 8.1). CONCLUSIONS: The results of our study suggest that serologic screening for CD may be considered in GD patients (1) with the HLA alleles typical for CD, (2) with an early onset of GD, or (3) a family history of autoimmunity. Moreover, the diagnosis of CD should be explored in euthyroid GD patients with nonspecific gastrointestinal symptoms. FAU - Miskiewicz, Piotr AU - Miskiewicz P FAU - Gos-Zajac, Agata AU - Gos-Zajac A FAU - Kurylowicz, Alina AU - Kurylowicz A FAU - Plazinska, Teresa Maria AU - Plazinska TM FAU - Franaszczyk, Maria AU - Franaszczyk M FAU - Bartoszewicz, Zbigniew AU - Bartoszewicz Z FAU - Kondracka, Agnieszka AU - Kondracka A FAU - Pirko-Kotela, Katarzyna AU - Pirko-Kotela K FAU - Rupinski, Maciej AU - Rupinski M FAU - Jarosz, Dorota AU - Jarosz D FAU - Regula, Jaroslaw AU - Regula J FAU - Ploski, Rafal AU - Ploski R FAU - Bednarczuk, Tomasz AU - Bednarczuk T LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20150629 PL - United States TA - Endocr Pract JT - Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists JID - 9607439 RN - 0 (HLA-DQ Antigens) RN - 0 (HLA-DQ2 antigen) RN - 0 (HLA-DRB1 Chains) SB - IM MH - Adolescent MH - Adult MH - Aged MH - Aged, 80 and over MH - Autoimmune Diseases/*genetics MH - Celiac Disease/complications/*genetics MH - Female MH - Genetic Predisposition to Disease MH - Graves Disease/complications/*genetics MH - HLA-DQ Antigens/*genetics MH - HLA-DRB1 Chains MH - *Haplotypes MH - Humans MH - Male MH - Middle Aged MH - Prospective Studies EDAT- 2015/06/30 06:00 MHDA- 2016/08/16 06:00 CRDT- 2015/06/30 06:00 PHST- 2015/06/30 06:00 [entrez] PHST- 2015/06/30 06:00 [pubmed] PHST- 2016/08/16 06:00 [medline] AID - S1530-891X(20)35731-1 [pii] AID - 10.4158/EP15700.OR [doi] PST - ppublish SO - Endocr Pract. 2015 Sep;21(9):993-1000. doi: 10.4158/EP15700.OR. Epub 2015 Jun 29.